SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-029069
Filing Date
2021-05-20
Accepted
2021-05-20 16:06:13
Documents
12
Period of Report
2021-05-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fdmt-8k_20210517.htm   iXBRL 8-K 56207
  Complete submission text file 0001564590-21-029069.txt   187108

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20210517.xsd EX-101.SCH 5836
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20210517_lab.xml EX-101.LAB 19467
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20210517_pre.xml EX-101.PRE 11678
5 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-8k_20210517_htm.xml XML 3566
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 21944519
SIC: 2836 Biological Products, (No Diagnostic Substances)